Pharmacological antagonism of EP2 receptor does not modify basal cardiovascular and respiratory function, blood cell counts, and bone morphology in animal models-Reference-Cited by-同舟云学术

Pharmacological antagonism of EP2 receptor does not modify basal cardiovascular and respiratory function, blood cell counts, and bone morphology in animal models

Published:2022-03 Issue: Volume:147 Page:112646
ISSN:0753-3322
Container-title:Biomedicine & Pharmacotherapy
language:en
Short-container-title:Biomedicine & Pharmacotherapy

Author:

Rawat Varun,Banik Avijit,Amaradhi Radhika,Rojas Asheebo,Taval Shashidharamurthy,Nagy Tamas,Dingledine Raymond,Ganesh Thota

Funder

National Institute on Aging

National Institute of Neurological Disorders and Stroke

National Institutes of Health

Publisher

Elsevier BV

Subject

Pharmacology,General Medicine

Reference58 articles.

1. Prostanoid receptor EP2 as a therapeutic target;Ganesh;J. Med. Chem.,2014

2. Molecular mechanisms underlying prostaglandin E2-exacerbated inflammation and immune diseases;Tsuge;Int. Immunol.,2019

3. Signaling pathways in inflammation and anti-inflammatory therapies;Yeung;Curr. Pharm. Des.,2018

4. The COX-2/prostanoid signaling cascades in seizure disorders;Rojas;Expert Opin. Ther. Targets,2019

5. Novel microglia cell line expressing the human EP2 receptor;Rojas;ACS Chem. Neurosci.,2019

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel NADPH Oxidase-2 Inhibitors as Potential Anti-Inflammatory and Neuroprotective Agents;Antioxidants;2023-08-23

2. Targeting EP2 Receptor for Drug Discovery: Strengths, Weaknesses, Opportunities, and Threats (SWOT) Analysis;Journal of Medicinal Chemistry;2023-07-17

3. Neuroinflammatory mediators in acquired epilepsy: an update;Inflammation Research;2023-02-06

4. Preclinical development of an EP2 antagonist for post-seizure cognitive deficits;Neuropharmacology;2023-02

5. Prostaglandin E2 in neuroblastoma: Targeting synthesis or signaling?;Biomedicine & Pharmacotherapy;2022-12